Interested in learning more about Burns & Levinson? Contact us today. We welcome all opportunities to explore how we can get things done for you and your business.
- Corporate
- Start-Ups & Emerging Growth Companies
- Finance
- Venture Capital & Private Equity
- International
- Real Estate
Legal & Business Issues In the World of Pharmaceuticals
Attorney Josef Volman and Glenn Cooper, former Chairman and CEO of Indevus Pharmaceuticals, review the Indevus acquisition - a $750 million tender offer deal completed in early 2009.
Completion of its Acquisition (Approx. $370 Million Up Front and up to $267 Million of Future Contingent Payments) by Endo Pharmaceuticals Holdings Inc. (Nasdaq: ENDP)